Go Pro

Origin Enterprises (OGN) Competitors

Origin Enterprises logo
GBX 366 0.00 (0.00%)
As of 07/24/2026

OGN vs. HCM, GRI, SLS, ERGO, and BMY

Should you buy Origin Enterprises stock or one of its competitors? MarketBeat compares Origin Enterprises with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Origin Enterprises include HUTCHMED (HCM), Grainger (GRI), Standard Life UK Smaller Companies Trust (SLS), Ergomed (ERGO), and Bloomsbury Publishing (BMY). These companies are all part of the "pharmaceutical products" industry.

How does Origin Enterprises compare to HUTCHMED?

Origin Enterprises (LON:OGN) and HUTCHMED (LON:HCM) are both small-cap pharmaceutical products companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, media sentiment, profitability, risk and earnings.

HUTCHMED has a net margin of 163.84% compared to Origin Enterprises' net margin of 1.78%. HUTCHMED's return on equity of 36.88% beat Origin Enterprises' return on equity.

Company Net Margins Return on Equity Return on Assets
Origin Enterprises1.78% 9.12% 2.96%
HUTCHMED 163.84%36.88%-5.90%

47.3% of Origin Enterprises shares are held by institutional investors. Comparatively, 20.4% of HUTCHMED shares are held by institutional investors. 3.2% of Origin Enterprises shares are held by insiders. Comparatively, 2.8% of HUTCHMED shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Origin Enterprises has a beta of 0.198, indicating that its stock price is 80% less volatile than the broader market. Comparatively, HUTCHMED has a beta of 0.428, indicating that its stock price is 57% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Origin Enterprises
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
HUTCHMED
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Origin Enterprises has higher revenue and earnings than HUTCHMED. HUTCHMED is trading at a lower price-to-earnings ratio than Origin Enterprises, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Origin Enterprises£2.13B0.18£3.62B£37.189.84
HUTCHMED£548.51M2.61-£52.98M£53.003.14

In the previous week, Origin Enterprises and Origin Enterprises both had 1 articles in the media. Origin Enterprises' average media sentiment score of 1.80 beat HUTCHMED's score of 0.00 indicating that Origin Enterprises is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Origin Enterprises
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
HUTCHMED
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Origin Enterprises beats HUTCHMED on 9 of the 14 factors compared between the two stocks.

How does Origin Enterprises compare to Grainger?

Grainger (LON:GRI) and Origin Enterprises (LON:OGN) are both small-cap pharmaceutical products companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, valuation, dividends and profitability.

Grainger pays an annual dividend of GBX 7.86 per share and has a dividend yield of 4.4%. Origin Enterprises pays an annual dividend of GBX 17.30 per share and has a dividend yield of 4.7%. Grainger pays out 28.8% of its earnings in the form of a dividend. Origin Enterprises pays out 46.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

48.1% of Grainger shares are owned by institutional investors. Comparatively, 47.3% of Origin Enterprises shares are owned by institutional investors. 1.5% of Grainger shares are owned by company insiders. Comparatively, 3.2% of Origin Enterprises shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Origin Enterprises has higher revenue and earnings than Grainger. Grainger is trading at a lower price-to-earnings ratio than Origin Enterprises, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Grainger£238.20M5.51-£1.11M£27.306.51
Origin Enterprises£2.13B0.18£3.62B£37.189.84

In the previous week, Grainger and Grainger both had 1 articles in the media. Origin Enterprises' average media sentiment score of 1.80 beat Grainger's score of 0.37 indicating that Origin Enterprises is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Grainger
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Origin Enterprises
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Grainger has a beta of 0.777, meaning that its share price is 22% less volatile than the broader market. Comparatively, Origin Enterprises has a beta of 0.198, meaning that its share price is 80% less volatile than the broader market.

Grainger has a net margin of 54.91% compared to Origin Enterprises' net margin of 1.78%. Origin Enterprises' return on equity of 9.12% beat Grainger's return on equity.

Company Net Margins Return on Equity Return on Assets
Grainger54.91% 6.53% 2.14%
Origin Enterprises 1.78%9.12%2.96%

Grainger currently has a consensus price target of GBX 225.60, suggesting a potential upside of 27.03%. Given Grainger's higher possible upside, equities research analysts plainly believe Grainger is more favorable than Origin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Grainger
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Origin Enterprises
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Origin Enterprises beats Grainger on 10 of the 17 factors compared between the two stocks.

How does Origin Enterprises compare to Standard Life UK Smaller Companies Trust?

Origin Enterprises (LON:OGN) and Standard Life UK Smaller Companies Trust (LON:SLS) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings.

47.3% of Origin Enterprises shares are held by institutional investors. 3.2% of Origin Enterprises shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Origin Enterprises had 1 more articles in the media than Standard Life UK Smaller Companies Trust. MarketBeat recorded 1 mentions for Origin Enterprises and 0 mentions for Standard Life UK Smaller Companies Trust. Origin Enterprises' average media sentiment score of 1.80 beat Standard Life UK Smaller Companies Trust's score of 0.00 indicating that Origin Enterprises is being referred to more favorably in the media.

Company Overall Sentiment
Origin Enterprises Very Positive
Standard Life UK Smaller Companies Trust Neutral

Origin Enterprises has higher revenue and earnings than Standard Life UK Smaller Companies Trust. Standard Life UK Smaller Companies Trust is trading at a lower price-to-earnings ratio than Origin Enterprises, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Origin Enterprises£2.13B0.18£3.62B£37.189.84
Standard Life UK Smaller Companies Trust£222.48M0.00N/A£217.40N/A

Origin Enterprises has a net margin of 1.78% compared to Standard Life UK Smaller Companies Trust's net margin of 0.00%. Origin Enterprises' return on equity of 9.12% beat Standard Life UK Smaller Companies Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Origin Enterprises1.78% 9.12% 2.96%
Standard Life UK Smaller Companies Trust N/A N/A N/A

Given Standard Life UK Smaller Companies Trust's higher possible upside, analysts clearly believe Standard Life UK Smaller Companies Trust is more favorable than Origin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Origin Enterprises
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Standard Life UK Smaller Companies Trust
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Origin Enterprises pays an annual dividend of GBX 17.30 per share and has a dividend yield of 4.7%. Standard Life UK Smaller Companies Trust pays an annual dividend of GBX 0.08 per share. Origin Enterprises pays out 46.5% of its earnings in the form of a dividend. Standard Life UK Smaller Companies Trust pays out 0.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

Origin Enterprises beats Standard Life UK Smaller Companies Trust on 12 of the 15 factors compared between the two stocks.

How does Origin Enterprises compare to Ergomed?

Ergomed (LON:ERGO) and Origin Enterprises (LON:OGN) are both small-cap pharmaceutical products companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, earnings, media sentiment, dividends, valuation and profitability.

Ergomed has a beta of 0.79, indicating that its stock price is 21% less volatile than the broader market. Comparatively, Origin Enterprises has a beta of 0.198, indicating that its stock price is 80% less volatile than the broader market.

Ergomed has a net margin of 9.87% compared to Origin Enterprises' net margin of 1.78%. Ergomed's return on equity of 18.08% beat Origin Enterprises' return on equity.

Company Net Margins Return on Equity Return on Assets
Ergomed9.87% 18.08% 10.16%
Origin Enterprises 1.78%9.12%2.96%

Origin Enterprises has higher revenue and earnings than Ergomed. Ergomed is trading at a lower price-to-earnings ratio than Origin Enterprises, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ergomed£152.09M0.00£15M£0.29N/A
Origin Enterprises£2.13B0.18£3.62B£37.189.84

In the previous week, Origin Enterprises had 1 more articles in the media than Ergomed. MarketBeat recorded 1 mentions for Origin Enterprises and 0 mentions for Ergomed. Origin Enterprises' average media sentiment score of 1.80 beat Ergomed's score of 0.00 indicating that Origin Enterprises is being referred to more favorably in the news media.

Company Overall Sentiment
Ergomed Neutral
Origin Enterprises Very Positive

Given Ergomed's higher possible upside, equities research analysts plainly believe Ergomed is more favorable than Origin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ergomed
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Origin Enterprises
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

71.1% of Ergomed shares are held by institutional investors. Comparatively, 47.3% of Origin Enterprises shares are held by institutional investors. 18.2% of Ergomed shares are held by insiders. Comparatively, 3.2% of Origin Enterprises shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Ergomed beats Origin Enterprises on 8 of the 15 factors compared between the two stocks.

How does Origin Enterprises compare to Bloomsbury Publishing?

Origin Enterprises (LON:OGN) and Bloomsbury Publishing (LON:BMY) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, risk, institutional ownership, valuation and profitability.

47.3% of Origin Enterprises shares are owned by institutional investors. Comparatively, 42.9% of Bloomsbury Publishing shares are owned by institutional investors. 3.2% of Origin Enterprises shares are owned by company insiders. Comparatively, 3.6% of Bloomsbury Publishing shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Origin Enterprises has a beta of 0.198, suggesting that its share price is 80% less volatile than the broader market. Comparatively, Bloomsbury Publishing has a beta of 0.419, suggesting that its share price is 58% less volatile than the broader market.

In the previous week, Bloomsbury Publishing had 3 more articles in the media than Origin Enterprises. MarketBeat recorded 4 mentions for Bloomsbury Publishing and 1 mentions for Origin Enterprises. Origin Enterprises' average media sentiment score of 1.80 beat Bloomsbury Publishing's score of 0.44 indicating that Origin Enterprises is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Origin Enterprises
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Bloomsbury Publishing
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Origin Enterprises pays an annual dividend of GBX 17.30 per share and has a dividend yield of 4.7%. Bloomsbury Publishing pays an annual dividend of GBX 15.62 per share and has a dividend yield of 2.6%. Origin Enterprises pays out 46.5% of its earnings in the form of a dividend. Bloomsbury Publishing pays out 47.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Origin Enterprises is clearly the better dividend stock, given its higher yield and lower payout ratio.

Origin Enterprises has higher revenue and earnings than Bloomsbury Publishing. Origin Enterprises is trading at a lower price-to-earnings ratio than Bloomsbury Publishing, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Origin Enterprises£2.13B0.18£3.62B£37.189.84
Bloomsbury Publishing£325.90M1.51£37.37M£32.8018.51

Bloomsbury Publishing has a net margin of 8.28% compared to Origin Enterprises' net margin of 1.78%. Bloomsbury Publishing's return on equity of 12.74% beat Origin Enterprises' return on equity.

Company Net Margins Return on Equity Return on Assets
Origin Enterprises1.78% 9.12% 2.96%
Bloomsbury Publishing 8.28%12.74%7.82%

Bloomsbury Publishing has a consensus price target of GBX 800, indicating a potential upside of 31.80%. Given Bloomsbury Publishing's higher possible upside, analysts clearly believe Bloomsbury Publishing is more favorable than Origin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Origin Enterprises
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Bloomsbury Publishing
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Bloomsbury Publishing beats Origin Enterprises on 10 of the 17 factors compared between the two stocks.

Get Origin Enterprises News Delivered to You Automatically

Sign up to receive the latest news and ratings for OGN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OGN vs. The Competition

MetricOrigin EnterprisesFarm Products IndustryDefensive SectorLON Exchange
Market Cap£393.40M£258.32M£8.33B£2.58B
Dividend Yield4.11%3.24%3.13%6.17%
P/E Ratio9.846.60888.56368.39
Price / Sales0.1867.74992,150.2984,422.84
Price / Cash0.029.00142.3327.89
Price / Book1.0710.339.737.41
Net Income£3.62B£375.04M£1.03B£5.89B
7 Day Performance1.67%2.93%-0.35%0.39%
1 Month Performance-5.89%3.18%-0.02%0.27%
1 Year Performance9,765.23%313.42%273.42%68.12%

Origin Enterprises Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OGN
Origin Enterprises
1.8104 of 5 stars
GBX 366
flat
N/AN/A£393.40M£2.13B9.8410,000
HCM
HUTCHMED
N/AGBX 177
+2.0%
N/A-35.5%£1.52B£548.51M3.341,760
GRI
Grainger
4.5472 of 5 stars
GBX 175.10
+1.5%
GBX 225.60
+28.8%
-14.4%£1.29B£238.20M6.41372
SLS
Standard Life UK Smaller Companies Trust
N/AN/AN/AN/A£715.41M£222.48M3.3710
ERGO
Ergomed
N/AN/AN/AN/A£701.00M£152.09M4,641.386

Related Companies and Tools


This page (LON:OGN) was last updated on 7/26/2026 by MarketBeat.com Staff.
From Our Partners